Phase 1 Vaccine Studies in the Times of Covid-19
Free webinar on 28 January 2021 at 16:00-17:45 CET
Invitation to our Early Medicines Development Community
COVID has highlighted the importance of Phase 1 trials with vaccines. And yet, only a handful of sponsors, Phase 1 sites and investigators have a thorough understanding of the science, methodology, ethics and logistics required to run such trials.
Our New Years EUFEMED webinar will provide you with cutting-edge insight into newest developments around such trials while also learning about the experience of others and providing an opportunity to discuss recommendations.
What to expect
| from 15:40 | dial-in |
| Moderator: | Jan de Hoon Center for Clinical Pharmacology, KU Leuven, Belgium |
| 16:00 | Welcome and Introduction |
| 16:10 | An overview of current vaccine platforms and the development of a new vaccine against SARS-CoV-2 Johan Neyts, Rega Institute, KU Leuven, Belgium Q&A |
| 16:40 | The challenges of setting up a Phase 1 vaccine trial during the Corona pandemic: The sponsor’s point of view Johan Van Hoof, Janssen Pharmaceutica, Beerse, Belgium Q&A |
| 17:10 | The challenges of conducting a Phase 1 vaccine trial during the Corona pandemic: The investigator’s point of view Wouter Botermans, Center for Clinical Pharmacology, KU Leuven, Belgium Q&A |
| 17:30 | General Discussion |
| 17:40 | Closing remarks |
| Registration | Free of charge (requested at the latest by 25/1/2021) |
| Organizer | EUFEMED www.eufemed.eu |
| Contact | via CSi Hamburg GmbH Email: eufemed2021@csihamburg.de Phone: +49 40 30770300 |
For registration and FAQ on participation: